Beyond basal-bolus insulin regimen: is it still the ultimate chance for therapy in diabetes?

All people with type 1 diabetes (T1D) need insulin to survive, with the hope to cut or slow down the devastating long-term micro and macrovascular complications. About one fourth of people with type 2 diabetes (T2D) uses insulin, either as the only antyhyperglycemic drug, or in combination with other glucose-lowering medications [1,2]. Every day, about 6 million diabetic people in the U.S. inject insulin to control their hyperglycemia.
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Source Type: research